Literature DB >> 7156659

Infections caused by Pseudomonas maltophilia with emphasis on bacteremia: case reports and a review of the literature.

J J Zuravleff, V L Yu.   

Abstract

Ten cases of Pseudomonas maltophilia bacteremia were identified over a five-year period at the University of Pittsburgh Medical Center. Our experience and a review of the literature show that P. maltophilia can cause a wide spectrum of disease. We present cases of pneumonia and infections of the biliary tract and urinary tract in which the organism was isolated simultaneously from blood. P. maltophilia endocarditis occurs in the context of iv drug abuse or as a postoperative complication of prosthetic valve surgery. Pseudobacteremia from contaminated equipment, disinfectants, and vascular catheters is the newest presentation for P. maltophilia infection. Hospitalization and prior antibiotic therapy are risk factors for serious P. maltophilia infection. Mortality due to P. maltophilia infection is low, despite the notable in vitro resistance of the organism to antibiotics. Trimethoprim-sulfamethoxazole, minocycline, doxycycline, and moxalactam are highly active in vitro against P. maltophilia. The triple combination of trimethoprim-sulfamethoxazole plus carbenicillin plus rifampin has been found to be synergistic in vitro and can be considered for serious infections.

Entities:  

Mesh:

Year:  1982        PMID: 7156659     DOI: 10.1093/clinids/4.6.1236

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  25 in total

1.  Pseudomonas maltophilia infections in neutropenic patients and the use of imipenem.

Authors:  K G Kerr; P M Hawkey; J A Child; D R Norfolk; A W Anderson
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

2.  Chronic dacryocystitis secondary to Stenotrophomonas maltophilia and Staphylococcus aureus mixed infection.

Authors:  Arzu Taskiran Comez; Asiye Koklu; Alper Akcali
Journal:  BMJ Case Rep       Date:  2014-06-20

3.  Demonstration and partial characterization of ADP-ribosylation in Pseudomonas maltophilia.

Authors:  C Edmonds; G E Griffin; A P Johnstone
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

4.  Prevalence of serotypes of Xanthomonas maltophilia from world-wide sources.

Authors:  B Schable; D L Rhoden; W R Jarvis; J M Miller
Journal:  Epidemiol Infect       Date:  1992-04       Impact factor: 2.451

5.  Critical evaluation of the AutoMicrobic system gram-negative identification card for identification of glucose-nonfermenting gram-negative rods.

Authors:  J J Plorde; J A Gates; L G Carlson; F C Tenover
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

6.  Isolation and characterization of novel giant Stenotrophomonas maltophilia phage phiSMA5.

Authors:  Hsiao-Chuan Chang; Chiy-Rong Chen; Juey-Wen Lin; Gwan-Han Shen; Kai-Ming Chang; Yi-Hsiung Tseng; Shu-Fen Weng
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

Review 7.  Infective endocarditis due to Stenotrophomonas (Xanthomonas) maltophilia.

Authors:  R G Munter; A M Yinnon; Y Schlesinger; C Hershko
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-05       Impact factor: 3.267

8.  Molecular epidemiology of Xanthomonas maltophilia colonization and infection in the hospital environment.

Authors:  F P Laing; K Ramotar; R R Read; N Alfieri; A Kureishi; E A Henderson; T J Louie
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

9.  Pseudomonas maltophilia exoenzyme activity as correlate in pathogenesis of ecthyma gangrenosum.

Authors:  E J Bottone; M Reitano; J M Janda; K Troy; J Cuttner
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

10.  Susceptibilities of 123 Xanthomonas maltophilia strains to clinafloxacin, PD 131628, PD 138312, PD 140248, ciprofloxacin, and ofloxacin.

Authors:  G A Pankuch; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.